Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
30 Jul 2024 - Andrew Penkethman - CEO & Managing Director - Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
31 Aug 2020 - Acorn Capital Resources and Energy Analyst Karina Bader talks about junior resource companies and how investors can try to make money as the companies move from explorers to developers to producers.
22 May 2023 - Kalamazoo Resources Limited (ASX:KZR) CEO and Chairman Luke Reinehr discusses plans to spin out the company's lithium projects into a new ASX-listed exploration company in an agreement with TSX-listed Canadian gold miner Karora Resources.
24 Jun 2020 - Acorn Capital, portfolio manager Rick Squire talks about the energy and resource sectors, some of the funds best ideas and outlook for commodities and energy prices as the world emerges from OCIVD-19 lockdown.
26 Apr 2021 - Praemium Limited (ASX:PPS) CEO and Managing Director Michael Ohanessian talks about the company's strong 1H21 results, the successful acquisition of Powerwrap, platform enhancements and outlook.
30 Aug 2023 - icetana Limited (ASX:ICE) Non-Executive Chair Matt Macfarlane discusses his transition from the CEO role, the company's artificial intelligence solution, annual recurring revenue growth, and the recent contract secured with the Sydney Opera House.
13 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Kieran Kennedy discuss the FY25 full-year results of Mirrabooka Investments (ASX:MIR).
24 Nov 2020 - Mitchell Services Limited (ASX:MSV) CEO Andrew Elf provides an update on the company's FY20 results, its strategy of becoming Australia’s leading drilling services provider and the robust state of the mining sector.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
13 Sep 2022 - Imdex Limited (ASX:IMD) CEO Paul House discusses FY22 financial and operational highlights, the first commercial contract for Blast Dog, growth opportunities and outlook.
